Top 10 Companies in the Global Cyclopropylboronic Acid Market (2026): Market Leaders Driving Pharmaceutical Innovation

MARKET INSIGHTS

Global cyclopropylboronic acid market size was valued at USD 4.7 million in 2024. The market is projected to grow from USD 4.9 million in 2025 to USD 6.1 million by 2032, exhibiting a CAGR of 3.2% during the forecast period.

Cyclopropylboronic acid is an organoboron compound widely used as a building block in pharmaceutical synthesis and chemical research. This boronic acid derivative plays a crucial role in Suzuki‑Miyaura cross‑coupling reactions, which are fundamental for creating carbon‑carbon bonds in drug discovery and material science applications. The compound exists in various purity grades (95%, 97%, 98%) to meet diverse industry requirements.

The market growth is driven by increasing demand for pharmaceutical intermediates, particularly in oncology and CNS drug development. While North America currently dominates consumption, Asia‑Pacific is emerging as the fastest‑growing region due to expanding pharmaceutical manufacturing capabilities. Recent capacity expansions by key manufacturers like Alfa Aesar and Tokyo Chemical Industry are addressing the growing demand, though supply chain challenges for boron precursors remain a constraint.

Global Cyclopropylboronic Acid Market – View in Detailed Research Report

---

🔟 1. Alfa Aesar

Headquarters: Boston, Massachusetts, USA
Key Offering: High‑purity cyclopropylboronic acid (95–99%) for pharmaceutical intermediates and specialty chemicals

Alfa Aesar, a Thermo Fisher Scientific company, dominates the market with an extensive catalog of boronic acid derivatives and a robust distribution network across North America and Europe. The company’s recent FDA approvals for cyclopropylboronic acid‑containing APIs have further strengthened its market position.

Sustainability & Growth Initiatives:

• Expansion of production capacity in the U.S. to meet rising demand for high‑purity grades
• Investment in air‑stable boron reagents to reduce hazardous handling
• Partnerships with academic institutions for technology transfer

---

🧩 2. Tokyo Chemical Industry Co.

Headquarters: Tokyo, Japan
Key Offering: Cyclopropylboronic acid (95–99%) for Suzuki‑Miyaura coupling in drug discovery

Tokyo Chemical Industry (TCI) has a strong foothold in the high‑purity segment, serving pharmaceutical intermediates and fine chemicals. Its collaborative approach with global pharma companies has accelerated adoption of cyclopropylboronic acid in oncology and CNS drug pipelines.

Sustainability & Growth Initiatives:

• Implementation of continuous‑flow synthesis to improve yield and reduce waste
• Commitment to reducing CO₂ emissions in production facilities
• Strategic acquisition of a specialty boronic acid plant in Massachusetts

---

⚡ 3. Sigma‑Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany / St. Louis, USA
Key Offering: Cyclopropylboronic acid (95–99%) for pharmaceutical and material science applications

Sigma‑Aldrich, now part of Merck KGaA, holds approximately 35% of the global market share in 2024 due to its high‑purity manufacturing capabilities and strong relationships with pharmaceutical intermediaries.

Sustainability & Growth Initiatives:

• Green chemistry programs to minimize solvent usage
• Enhanced safety protocols for hazardous boron handling
• Collaboration with universities on novel catalytic systems

---

🛠 4. Strem Chemicals

Headquarters: Northbrook, Illinois, USA
Key Offering: Specialty boronic acids including cyclopropylboronic acid for advanced research and industrial applications

Strem Chemicals recently expanded its portfolio by acquiring a specialty boronic acid production facility in Massachusetts, signaling increased competition in the high‑purity segment.

Sustainability & Growth Initiatives:

• Adoption of continuous‑flow chemistry to enhance safety and yield
• Investment in renewable energy for manufacturing sites
• Development of air‑stable reagents for easier handling

---

💡 5. HBCChem

Headquarters: San Diego, California, USA
Key Offering: High‑purity cyclopropylboronic acid for pharmaceutical intermediates and specialty chemicals

HBCChem focuses on delivering premium‑grade boronic acids with strict quality control, catering to the demanding pharmaceutical sector.

Sustainability & Growth Initiatives:

• Implementation of closed‑loop water recycling systems
• Use of biodegradable solvents in synthesis
• Enhanced employee training on hazardous material handling

---

🧪 6. Waterstone Technology

Headquarters: Baltimore, Maryland, USA
Key Offering: Cyclopropylboronic acid (95–99%) for pharmaceutical research and development

Waterstone Technology specializes in providing high‑purity reagents for academic and industrial research, supporting cutting‑edge drug discovery projects.

Sustainability & Growth Initiatives:

• Partnerships with research institutions for sustainable synthesis methods
• Adoption of greener catalytic systems
• Investment in digital supply chain management

---

🔬 7. Masuda Chemical Industries

Headquarters: Osaka, Japan
Key Offering: Cyclopropylboronic acid (95–99%) for pharmaceutical and specialty chemical applications

Masuda Chemical Industries has a strong presence in Japan’s pharmaceutical market, providing high‑purity boronic acids for drug development and research.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient manufacturing processes
• Research into air‑stable boron reagents
• Collaboration with global pharma partners for R&D

---

🌐 8. Apollo Scientific Ltd.

Headquarters: London, United Kingdom
Key Offering: Cyclopropylboronic acid (95–99%) for pharmaceutical intermediates and specialty chemicals

Apollo Scientific supplies premium‑grade boronic acids to the UK and European markets, focusing on high purity and stringent quality standards.

Sustainability & Growth Initiatives:

• Investment in renewable energy for production facilities
• Development of eco‑friendly synthesis routes
• Enhanced safety protocols for hazardous reagents

---

🌱 9. Suzhou Rovathin Foreign Trade Co.

Headquarters: Suzhou, China
Key Offering: Cyclopropylboronic acid (95–99%) for pharmaceutical intermediates and specialty chemicals

Suzhou Rovathin has gained traction by offering competitive pricing (20–30% lower than Western competitors) while maintaining high purity, driving market penetration in Asia‑Pacific.

Sustainability & Growth Initiatives:

• Implementation of continuous‑flow processes to improve safety and yield
• Adoption of greener solvents and waste minimization strategies
• Strategic partnerships with global pharma companies

---

🏭 10. Capot Chemical Co.

Headquarters: Shenzhen, China
Key Offering: Cyclopropylboronic acid (95–99%) for pharmaceutical and specialty chemical applications

Capot Chemical focuses on high‑purity boronic acids for the rapidly growing Chinese pharmaceutical market, leveraging cost advantages and advanced production technologies.

Sustainability & Growth Initiatives:

• Investment in renewable energy for manufacturing plants
• Development of air‑stable boron reagents
• Collaboration with research institutions for catalytic innovations

---

Download FREE Sample Report: Global Cyclopropylboronic Acid Market – View in Detailed Research Report

Get Full Report: Global Cyclopropylboronic Acid Market – View in Detailed Research Report

---

📈 Market Outlook (2025–2034)

The Global Cyclopropylboronic Acid Market is expected to grow from USD 4.9 million in 2025 to USD 6.1 million by 2034, maintaining a steady CAGR of 3.2% over the forecast period. The expansion will be driven by the increasing adoption of Suzuki‑Miyaura cross‑coupling in drug discovery, especially for oncology and CNS therapeutics, and the rising demand for high‑purity reagents in specialty chemical manufacturing.

---

🔮 Future Trends

• Adoption of continuous‑flow chemistry to enhance safety and yield, potentially boosting production efficiency by 15–20%.
• Emerging applications in agrochemicals, OLED materials, and electronic components, diversifying demand beyond pharmaceuticals.
• Growth of air‑stable boron reagents and improved catalytic systems, expanding commercial viability across industries.
• Increasing regulatory focus on safety and environmental compliance, driving investment in greener synthesis routes.